HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
NNNN
Anbio Biotechnology Class A Ordinary Shares
There isn't enough reported data to score NNNN yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
NNNN Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Stable | |
| Strong |
NNNN's profitability and balance sheet are currently strong, and its cash flow is stable. There isn't enough data to rate its revenue.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
NNNN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 26x | $3.80 | — |
| Cheap | 42x | $6.24 | +64% |
| Fair | 162x | $24.23 | +538% |
| Expensive | 420x | $63.06 | +1559% |
Historical ranges are pointers, not guarantees.
NNNN's PE is 26x, but its earnings don't support one, so it isn't a reliable read right now.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
NNNN Forward outlook
There aren't enough analyst estimates for NNNN to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
NNNN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.15 | +150% |
| Q4 2024 | $0.06 | -14% |
| Q4 2023 | $0.07 | -73% |
NNNN has the edge over HIMS in the latest year-over-year earnings comparison.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
NNNN has the stronger quarterly revenue trend. Revenue is up 49% for HIMS versus up 162% for NNNN.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
NNNN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $8.6M | +5.6% |
| Q4 2024 | $8.2M | +107% |
| Q4 2023 | $4M | +39% |
| Q3 2023 | $1.8M | -36% |
| Q2 2023 | $3.3M | -63% |
| Q1 2023 | $1.5M | -83% |
NNNN's revenue is growing: $9M last quarter, up 162% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 67% | +20 points |
| Q4 2024 | 24% | -22 points |
| Q4 2023 | 15% | +14 points |
| Q3 2023 | 15% | +14 points |
| Q2 2023 | 46% | -11 points |
| Q1 2023 | 46% | -11 points |
| Q4 2022 | 1.2% | N/A |
| Q3 2022 | 0.6% | N/A |
NNNN's operating margin was 67% last quarter, up 20 points from the same quarter a year ago, near the top of its range since 2022.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
NNNN has the stronger cash trend. Its trailing FCF is down 79% versus its history, compared with HIMS at down 84%.
NNNN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2023 | -$1.3M | -140% |
| Q3 2023 | -$616.6K | -137% |
| Q2 2023 | $2.3M | +324% |
| Q1 2023 | $1.1M | +96% |
NNNN usually generates cash, though not every quarter: the latest was −$1M, but it generated $1M over the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over NNNN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
NNNN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +1.4M shares |
| 1 year | +3.3% | +1.4M shares |
NNNN has 44M diluted shares, up 3.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
NNNN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -4.1x | Net Cash |
| Q2 2023 | -6.7x | Net Cash |
| Q4 2022 | -0.6x | Net Cash |
NNNN has more cash than debt.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
NNNN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.4 | Neutral |
| Stochastic | 5.5 | Oversold |
NNNN's weekly RSI is 32 (neutral) and its Stochastic is 6 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
NNNN PE vs Healthcare Sector
| Metric | NNNN | Sector median | Relative |
|---|---|---|---|
| PE | 26x | 26x | Same PE |
| PE % | 4 | 72 | 68 pts below |
NNNN is trading at 26x earnings, in line with the Healthcare sector's median of 26x, though its earnings don't support one.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
NNNN has stronger trend alignment. HIMS is above 0 of 5 weekly averages versus NNNN above 0 of 3.
NNNN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.31 | 12% below |
| 20 week MA | $6.89 | 45% below |
| 50 week MA | $18.7 | 80% below |
NNNN is in a downtrend: it's below all three of its weekly moving averages, and 80% below its 50-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over NNNN on returns for 2026, with the stronger performance.
NNNN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $5.77 | $33.5 | +481% |
| 2026 YTD | $33.5 | $3.80 | -89% |
NNNN has finished every year since 2025 higher, and it's down 89% so far in 2026.